DRAGSA 96 LLC - 11 Jan 2022 Form 3 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
10%+ Owner
Signature
/s/ Scott M. Hendler signing on behalf of O. Andreas Halvorsen (2)
Issuer symbol
AMLX
Transactions as of
11 Jan 2022
Net transactions value
$0
Form type
3
Filing time
21 Jan 2022, 16:10:09 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AMLX Common Stock 2,300,000 11 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The following persons affiliated with DRAGSA 96 LLC separately reported these securities on Form 4 filed January 13, 2022: Andreas Halvorsen, David C. Ott, Rose S. Shabet, Viking Global Investors LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, and Viking Global Opportunities Illiquid Investments Sub-Master LP.

Remarks:

(2) Scott M. Hendler is signing on behalf of Mr. Halvorsen, Mr. Ott and Ms. Shabet, each as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, as manager of DRAGSA 96 LLC, pursuant to authorization and designation letters dated February 9, 2021, which were filed with the Securities and Exchange Commission on June 7, 2021.